PBYI vs GILD: Which Stock is Better?
Side-by-side comparison of Puma Biotechnology Inc and Gilead Sciences Inc in 2026
PBYI
Puma Biotechnology Inc
—
GILD
Gilead Sciences Inc
$136.30
Key Metrics Comparison
| Metric | PBYI | GILD | Winner |
|---|---|---|---|
| Market Cap | $165.29M | $160.15B | GILD |
| P/E Ratio | 4.27 | 17.55 | PBYI |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze PBYI
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is PBYI or GILD a better investment?
Comparing PBYI and GILD: Puma Biotechnology Inc has a market cap of $165.29M while Gilead Sciences Inc has $160.15B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between PBYI and GILD?
PBYI (Puma Biotechnology Inc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: PBYI or GILD?
Based on P/E ratios, PBYI trades at a lower multiple (4.3x vs 17.5x).
Which is growing faster: PBYI or GILD?
Both PBYI and GILD show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: PBYI or GILD?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: PBYI or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $160.15B compared to $165.29M for PBYI.
Should I buy PBYI or GILD in 2026?
Both PBYI and GILD have investment merit. PBYI trades at $N/A while GILD trades at $136.30. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between PBYI and GILD stock?
Key differences: Market Cap ($165.29M vs $160.15B), P/E Ratio (4.3x vs 17.5x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy PBYI or GILD in 2026?
The choice between PBYI and GILD depends on your investment goals. GILD shows higher revenue growth (0.0%). GILD has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between PBYI and GILD?
PBYI (Puma Biotechnology Inc) has a market cap of $165.29M, while GILD (Gilead Sciences Inc) has a market cap of $160.15B. GILD is the larger company by market value.